Real-World Evidence of Differences in Biomarkers of Exposure to Select harmful and Potentially harmful Constituents and Biomarkers of Potential harm Between adult E-Vapor Users and adult Cigarette Smokers.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Oliveri (2020)
Metal exposure and biomarker levels among e-cigarette users in Spain.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Olmedo (2021)
Longitudinal investigation of the bidirectional associations between initiation of e-cigarettes and other substances in adolescents.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Ortega (2021)
Impact of gestational electronic cigarette vaping on amino acid signature profile in the pregnant mother and the fetus.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Orzabal (2021)
E-cigarette Transitions among US Youth and adults: Results from the Population assessment of Tobacco and health Study (2013-2018).
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Osibogun (2022)
adolescent E-cigarette Users at highest Risk of Cigarette Smoking Intention.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Owotomo (2021)
Smoking Intention and Progression From E-Cigarette Use to Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Owotomo (2020)
Urinary Cotinine and Nicotine Dependence Levels in Regular Male Electronic Cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Pamungkasninhsih (2021)
Electronic cigarette use among adults in 14 countries: a cross-sectional study.
Individual Clinical
User Topography
Pan (2022)
Lactate Dehydrogenase Levels in the Saliva of Cigarette and E-Cigarette Smokers (Vapers): a Comparative analysis.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Pandarathodiyil (2021)